Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel inhibitors of CDK2 and other kinases under study at Schering-Plough

May 14, 2004

U. of Leiden researchers identify novel inhibitors of GST P1-1

May 14, 2004

Further data on antitumor activity of PEP-005 supporting use as topical anti-skin cancer agent

May 14, 2004

Abraxane NDA accepted for filing

May 13, 2004

Sysmex collaboration to test automated cervical cancer screening technology

May 12, 2004

New phase II trial for Aplidin in SCLC

May 12, 2004

Five series of ALK5 kinase inhibitors presented by Pfizer

May 12, 2004

Opioid growth factor phase I trial in patients with advanced inoperable pancreatic carcinoma

May 12, 2004

Mayne launches Paxene in E.U.

May 11, 2004

Schering AG claims CDK inhibitors with utility in cancer and other disorders

May 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...